ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Montélukast Sandoz® granulé; Montélukast Sandoz® comprimés â mâcher; Montélukast Sandoz® comprimés pelliculés:Sandoz Pharmaceuticals AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
R03DC03 - MontelukastATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R03 - Drugs for Obstructive Airway Diseases
 
R03D - Other Systemic Drugs for Obstructive Airway Diseases

Theophyllines are classified in this group. Other respiratory stimulants are classified in R07AB - Respiratory stimulants.
Corticosteroids for systemic use, see H02.
Sympathomimetics for systemic treatment of rhinitis, see R01BA.

This group comprises mainly the xanthines. The DDDs for these substances are based on treatment of obstructive lung diseases.

R03DC - Leukotriene Receptor Antagonists

Combinations with antihistamines (R06A) are classified in this group.

R03DC03 - Montelukast
Concentr.Adm.RouteNote
 O 
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home